← All trials
NCT05254249
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 7, 2022
- Primary completion
- Aug 31, 2022
- Completion date
- Oct 31, 2022
- First posted
- Feb 24, 2022
- Last posted
- Feb 24, 2022
- Enrollment
- 75
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dr. Soetomo General HospitalLead sponsor
- Airlangga UniversityCollaborator
- Dr. Soetomo General HospitalReponsible party - principal investigator
- Dr. Soetomo General HospitalStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.